65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award
Ended Federal Supply Schedule Awarded Last action
- Contract number
- 36F79723D0194
- Awardee
-
Acorda Therapeutics, Inc. UEI R5D3FUPFFPK4
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 2
Award facts
- Opportunity
-
- M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment Pre-Solicitation · M5Q50A03R8 · Posted Jun 21, 2018
- Last date to order 100% complete
- IDV ceiling
- $16,372,670.00
- Award type
- Multiple award
- Who can order
- All agencies
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs (VA) has awarded Acorda Therapeutics, Inc., a biotechnology company specializing in neurological therapies, an IDV Federal Supply Schedule contract (36F79723D0194) valued at over $16.3 million. This multiple-award contract covers the procurement of drugs, pharmaceuticals, and hematology-related products through September 2028.
Under this IDV, the VA Veterans Integrated Service Network 12 has issued firm fixed-price delivery orders for Acorda's Levodopa 42mg inhalation capsules, used to treat Parkinson's disease symptoms. These orders have ranged from approximately $42,000 to over $500,000. Additionally, Acorda holds two VA Blanket Purchase Agreements for its Inbrija and Ampyra products, which are used to manage motor symptoms in Parkinson's disease and multiple sclerosis. These agreements, valued at $5.5 million and $7.5 million, provide streamlined procurement of these neurological medications for VA medical facilities nationwide. The majority of these contract awards did not involve set-asides, indicating that Acorda competed on an unrestricted basis.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Levodopa 42MG inhl 60/BT | Veterans Integrated Service Network 15 (VHA) | $493,607 | |
| Levodopa 42MG inhl - 60 caps | Veterans Integrated Service Network 15 (VHA) | $444,505 |
IDV awards
| IDV | Agency | Ceiling | Awarded |
|---|---|---|---|
| 36E79724A0005 | National Acquisition Center (VA) | $5,500,000 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36F79723D0194?
36F79723D0194 was awarded to Acorda Therapeutics, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on September 15, 2023.
How much is contract 36F79723D0194 worth?
36F79723D0194's own ceiling is $16,372,670.
How many orders have been placed under contract 36F79723D0194?
2 orders have been placed under 36F79723D0194, the latest on May 21, 2024.
Who can order from contract 36F79723D0194?
36F79723D0194 is a multiple award federal supply schedule. All agencies can place orders on it.
Was contract 36F79723D0194 competed?
The extent of competition for 36F79723D0194 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV